Indian Emulsifiers Ltd Q1 FY27 Earnings Analysis

- FY26 revenue growth was lower than previously guided (60% vs expected 100%) due to unforeseen global issues and February-March market panic. - Australia market shipment recently started; targeted revenue of ₹75 crore cumulatively over FY26-FY28 expected. - New American subsidiary set up; contribution to revenue expected from FY27 onwards, targeting oil, gas, and other industries. - Current capacity supports approx. ₹230-260 crore revenue; new Greenfield facility (400-500 MT capacity) expected operational by end FY27, boosting capacity. - Additional adjoining land acquired for QC, R&D, and food-grade emulsifier products with certifications; expected addition by early FY28. - The company anticipates scaling volumes aggressively with gradual margin improvements as procurement and macroeconomic conditions stabilize. - Management confident in long-term growth by expanding capacity, deepening market footprint, and product diversification aligned with upcoming facilities and certifications.

- FY26 saw strong growth: Revenue +57%, EBITDA +24.22%, PAT +21.83%. - Margins moderated due to prioritizing volume growth and geographic expansion. - Expect gradual margin improvement driven by scale efficiencies and better procurement. - Increased working capital deployment reflects expansion; cash conversion cycle remains stable. - New Greenfield facility to be operational by end FY27, substantially expanding capacity. - International markets (Australia, USA) expected to contribute growing revenue. - Procurement improvements and macroeconomic stabilization anticipated to support better bottom-line. - Rights issue timing and pricing will be decided considering market conditions; focus on long-term value. - EBITDA margin guidance remains in a broad range (historically around 19-20%), with some fluctuations expected during growth phase. - Volume-driven margin changes projected to stabilize with volume gains and product mix improvements. - Long-term strategy focuses on scaling capacity, operational efficiency, and sustained earnings growth over 3-5 years.

- The company is undertaking a Greenfield project on plot C3, expected to be operational by end of FY27, adding 400 to 500 metric tons capacity. - An adjoining plot was purchased in February to expand QC and R&D facilities and build a food-grade emulsifier facility with required certification; expected online by end FY27 or early FY28. - The new food-grade facility will add 200 to 250 metric tons of capacity, though exact numbers may vary due to certification. - Space provisions exist on the new plot to potentially add another 300 to 500 metric tons capacity in the future. - The rights issue in November funded the upcoming capacity addition and capital expenditure. - Additional debt has been taken to support expansion of QC, R&D, and new food-grade facility. - A proposed future fundraise is under application with the exchange for multiple objects, including investment in sister companies and further growth capital.

- The company has applied for in-principle approval from the exchange to raise funds through a new fundraising round. - The proposed fundraise aims to support growth opportunities, including capital expenditure and operational funding. - This fundraise is distinct from the last rights issue conducted six months ago, which was primarily for additional capacity build-up. - The promoter has limited resources, so equity fundraising supplements debt capacity. - Debt remains the company's preferred financing option, but access is constrained for SMEs due to collateral and cost challenges. - As the company grows, it expects improved access and terms for debt financing. - Any future fundraising details will only be finalized after exchange approval and will be communicated through official channels.

- The transcript does not explicitly mention the current or expected order book or pending orders in specific numerical terms. - However, there are references to new business uptake and sales expectations: - Australia: Expect uptake this year and next with targets of about ₹75 crore cumulative revenue over three years. - American subsidiary: Started contributing revenue already with expected scaling up in FY27 onwards. - Capacity expansion is underway to meet growing demand, indicating an anticipation of increased orders. - The company is focused on scaling capacity, deepening footprint, and operational efficiency for growth. - No detailed quantitative order book or backlog figures were disclosed in the provided transcript.